InBody Co.,Ltd (KOSDAQ: 041830)

Market Cap	273.15B
Revenue (ttm)	191.30B
Net Income (ttm)	31.81B
Shares Out	12.82M
EPS (ttm)	2,441.68
PE Ratio	8.72
Forward PE	6.97
Dividend	350.00 (1.64%)
Ex-Dividend Date	n/a

Volume	33,827
Open	21,800
Previous Close	21,800
Day's Range	21,300 - 22,300
52-Week Range	20,700 - 30,700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 21, 2025

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1996
• Employees: 312
• Stock Exchange: KOSDAQ
• Ticker Symbol: 041830

Financial Performance

In 2023, InBody Co.,Ltd's revenue was 170.35 billion, an increase of 6.47% compared to the previous year's 160.00 billion. Earnings were 36.72 billion, an increase of 8.60%.